2018
2018 4
............................................................................................................................................. 1
...................................................................................................................................... 2
.............................................................................................................................................. 7
............................................................................................................................................ 13
.................................................................................................................................... 27
2018
(
)
1
2018
284,615,012.67 229,539,932.98 23.99%
42,789,001.00 75,549,674.60 -43.36%
39,006,399.78 49,252,805.86 -20.80%
73,389,657.57 70,119,683.98 4.66%
/ 0.11 0.19 -42.11%
/ 0.11 0.19 -42.11%
2.07% 3.85% -1.78%
2,787,233,759.01 2,773,013,798.83 0.51%
2,085,360,506.41 2,051,962,363.07 1.63%
401,000,000
-25,692.68
2,291,563.18
2
2018
1,762,083.23
421,227.44
666,579.95
3,782,601.22 --
1 ——
1
4 2016 5 20
2016 515 2017 2
2017 7 19 36
EGFR
1 6
171 100 400
2018 CSCO
3
2018
EGFR BRAIN
EGFR NSCLC
EGFR
2
3
EGFR-TKI
2
1
2
3
“ ”
1 10
4
2018
20,241 0
10
19.97% 80,064,000 80,064,000 3,357,300
14.33% 57,456,000 57,456,000 32,292,260
9.61% 38,520,000 38,520,000 0
6.73% 27,000,000 27,000,000 18,900,000
WANG YINXIANG 5.84% 23,425,560 23,425,560 10,000,000
BETA PHARMA, INC. 5.55% 22,236,335 0 0
4.57% 18,309,029 0 0
LAV Equity (Hong Kong) Co.,
2.69% 10,800,000 0 0
Limited
ZHANG HANCHENG 2.32% 9,317,200 0 0
Sequoia Capital China GFII
2.26% 9,068,209 0 0
(HK) Limited
10
BETA PHARMA, INC. 22,236,335 22,236,335
18,309,029 18,309,029
LAV Equity (Hong Kong) Co., Limited 10,800,000 10,800,000
ZHANG HANCHENG 9,317,200 9,317,200
Sequoia Capital China GFII (HK) Limited 9,068,209 9,068,209
5,757,388 5,757,388
5,718,000 5,718,000
( ) 2,780,098 2,780,098
2,296,439 2,296,439
1,723,960 1,723,960
5
2018
26.6993% 680,784
0.1698% WANG YINXIANG
5.84% WANG YINXIANG
TAN FENLAI 1.08%
TAN FENLAI WANG YINXIANG
WANG YINXIANG
33.7891%
10 10
2 10
3
6
2018
5,636,172.21 3,638,455.38 54.91%
38,710,678.52 74,562,478.28 -48.08%
20,741,016.69 15,151,111.10 36.89%
-24,564,496.38 -15,173,638.73 61.89%
12,684,022.39 9,440,352.37 34.36%
93,046,343.98 61,587,396.84 51.08%
-3,810.52
5,070,038.81 -136,639.48
%
41,631,547.76 75,329,956.59 -44.73%
350,979,601.51 267,444,411.30 31.23%
3,904,186.51 27,201,625.95 -85.65%
139,482,514.68 97,005,811.87 43.79%
56,867,808.22 439,133,644.44 -87.05%
148,535,877.45 108,394,019.72 37.03%
57,156,368.00 149,994,000.00 -61.89%
50,000,000.00 -
2018 40.35% 28,461.50
23.99% 4,278.90 43.36%
3,900.64 20.80%
1
1,925.89
2 2,441.02
7
2018
3 1043.83
5
5
5
1
40.35%
2
2018 4 Ensartinib
2018 2-3 IND
BPI-16350
3
8
2018
1 2014 10 25 Xcovery Holding Company LLC Xcovery Holdings, Inc.
X-396 2017 3 27
Xcovery Holding Company LLC
300
Xcovery Holding Company LLC 2017
Xcovery D Xcovery 86.24% Xcovery Holding
Company LLC
2
GUOJIAN XIE BETA BETA
PHARMA SCIENTIFIC INC. DON ZHANG 2016 10 26 2017
SHANSHAN SHAO HONGLIANG CHU QIAN LIU
SONG LU 2016 10 26 2017
GUOJIAN XIE
2017 08 08 2017-061 2017
2018-002
BPI-16350 2018 02 01 BPI-16350
Xcovery D-3 2018-008
2018 03 12
Equinox
65,735
0
882.98
9
2018
0
59,183.42
0.00%
( (3)
(1) (2) (2)/(1)
)
2023
24,000 24,000 794.01 19,545.24 81.44% 12 31
2017
38,000 38,000 0 38,010.83 100.03% 09 30 13,618.25 32,189.63
2017
1,300 1,300 69.91 1,287.02 99.00% 07 31
2018
2,435 2,435 19.06 340.33 13.98% 12 31
-- 65,735 65,735 882.98 59,183.42 -- -- 13,618.25 32,189.63 -- --
-- -- -- -- -- --
-- -- -- -- -- --
-- -- -- -- --
-- 65,735 65,735 882.98 59,183.42 -- -- 13,618.25 32,189.63 -- --
10
2018
2016 11 2 46,003.50
2016 11 12 46,003.50 2016 11
22
2014 2015
11
2018
20%
2016 12 8 2016
2016-014 2016 12 21 2016-017
2017
257,727,409.55 322,266,228.64
10% 32,226,622.86 290,039,605.78
805,328,847.70 2016 72,180,000.00
1,023,188,453.48
2018 4 4 2017
401,000,000 10 1.5
60,150,000.00
12
2018
1
182,774,004.88 213,272,623.49
74,405,988.38 91,973,343.11
30,124,516.88 23,324,380.69
5,636,172.21 3,638,455.38
116,128,555.52 99,756,076.06
38,710,678.52 74,562,478.28
447,779,916.39 506,527,357.01
134,077,218.94 136,992,499.61
13
2018
15,269,416.56 15,269,416.56
449,233,604.22 454,770,238.29
460,766,771.89 408,379,933.28
547,299,785.92 545,670,165.84
306,205,762.51 277,813,121.15
413,584,000.09 413,584,000.09
1,919,602.18 2,094,111.46
6,343,933.31 7,159,208.54
4,753,747.00 4,753,747.00
2,339,453,842.62 2,266,486,441.82
2,787,233,759.01 2,773,013,798.83
250,000,000.00 200,000,000.00
10,000,000.00 10,000,000.00
93,444,621.64 121,788,288.43
396,438.00 75,304.80
35,278,939.93 57,335,849.62
20,741,016.69 15,151,111.10
216,672.76 422,430.55
14
2018
90,221,629.67 112,418,561.92
500,299,318.69 517,191,546.42
100,000,000.00 100,000,000.00
33,825,752.56 34,648,615.74
55,236,025.48 54,642,544.31
189,061,778.04 189,291,160.05
689,361,096.73 706,482,706.47
401,000,000.00 401,000,000.00
600,132,530.29 600,132,530.29
-24,564,496.38 -15,173,638.73
144,023,847.49 144,023,847.49
15
2018
964,768,625.01 921,979,624.02
2,085,360,506.41 2,051,962,363.07
12,512,155.87 14,568,729.29
2,097,872,662.28 2,066,531,092.36
2,787,233,759.01 2,773,013,798.83
2
156,884,135.92 154,033,483.24
74,405,988.38 91,973,343.11
8,560,038.95 1,513,038.95
527,248,473.73 480,760,730.33
116,128,555.52 99,756,076.06
20,000,000.00 55,000,000.00
903,227,192.50 883,036,671.69
59,588,895.68 59,588,895.68
1,023,605,106.56 1,023,605,106.56
433,311,134.72 438,255,509.24
16
2018
151,988,657.62 118,624,899.16
120,374,186.83 104,268,550.92
112,482,738.77 82,454,429.58
6,573,733.86 7,389,009.09
4,753,747.00 4,753,747.00
1,912,678,201.04 1,838,940,147.23
2,815,905,393.54 2,721,976,818.92
250,000,000.00 200,000,000.00
10,000,000.00 10,000,000.00
37,887,061.97 37,915,556.37
396,438.00 75,304.80
34,304,852.02 54,735,146.16
23,486,330.37 14,837,190.94
216,672.76 422,430.55
59,516,105.59 72,888,537.39
415,807,460.71 390,874,166.21
100,000,000.00 100,000,000.00
17
2018
33,825,752.56 34,648,615.74
1,835,731.71 1,242,250.54
135,661,484.27 135,890,866.28
551,468,944.98 526,765,032.49
401,000,000.00 401,000,000.00
626,999,485.46 626,999,485.46
144,023,847.49 144,023,847.49
1,092,413,115.61 1,023,188,453.48
2,264,436,448.56 2,195,211,786.43
2,815,905,393.54 2,721,976,818.92
3
284,615,012.67 229,539,932.98
284,615,012.67 229,539,932.98
235,537,155.06 168,882,396.90
12,684,022.39 9,440,352.37
18
2018
5,329,050.60 4,571,251.33
119,386,544.36 93,400,871.21
93,046,343.98 61,587,396.84
5,070,038.81 -136,639.48
21,154.92 19,164.63
“ ”
“ ”
1,762,083.23 1,518,586.68
-2,381,077.89
“-”
“-”
-25,692.68 -102,757.05
791,463.18
“ ” 51,605,711.34 62,073,365.71
2,124,265.66 27,320,585.12
202,938.22 180,000.00
“ ” 53,527,038.78 89,213,950.83
11,895,491.02 13,883,994.24
“ ” 41,631,547.76 75,329,956.59
41,631,547.76 75,329,956.59
“ ”
“ ”
42,789,001.00 75,549,674.60
-1,157,453.24 -219,718.01
-9,390,857.65 -926,349.25
-9,390,857.65 -926,349.25
19
2018
1.
2.
-9,390,857.65 -926,349.25
1.
2.
3.
4.
5. -9,390,857.65 -926,349.25
6.
32,240,690.11 74,403,607.34
33,398,143.35 74,623,325.35
-1,157,453.24 -219,718.01
0.11 0.19
0.11 0.19
20
2018
4
284,615,012.67 229,370,121.66
12,684,022.39 9,440,352.37
5,315,973.16 4,571,251.33
119,386,544.36 93,400,871.21
67,422,898.58 60,094,050.58
3,108,132.42 -177,613.71
21,154.92 19,164.63
“ ”
“ ”
1,762,083.23 3,810,403.47
-89,261.10
“-”
-25,692.68 -102,757.05
791,463.18
“ ” 79,204,140.57 65,729,691.67
2,118,950.80 27,320,585.12
202,938.22 180,000.00
“ ”
81,120,153.15 92,870,276.79
11,895,491.02 13,883,994.24
“ ” 69,224,662.13 78,986,282.55
69,224,662.13 78,986,282.55
“ ”
“ ”
1.
2.
21
2018
1.
2.
3.
4.
5.
6.
69,224,662.13 78,986,282.55
0.17 0.20
0.17 0.20
5
350,979,601.51 267,444,411.30
22
2018
3,909,501.37 27,201,625.95
354,889,102.88 294,646,037.25
17,325,371.63 15,093,270.13
83,958,260.46 75,582,563.55
40,733,298.54 36,844,707.72
139,482,514.68 97,005,811.87
281,499,445.31 224,526,353.27
73,389,657.57 70,119,683.98
56,867,808.22 439,133,644.44
8,718.00 120,300.00
56,876,526.22 439,253,944.44
148,535,877.45 108,394,019.72
57,156,368.00 149,994,000.00
23
2018
205,692,245.45 258,388,019.72
-148,815,719.23 180,865,924.72
50,000,000.00
50,000,000.00
3,758,361.12
10,383,446.50
3,758,361.12 10,383,446.50
46,241,638.88 -10,383,446.50
-1,314,195.83 -41,560.28
-30,498,618.61 240,560,601.92
213,272,623.49 153,921,641.42
182,774,004.88 394,482,243.34
6
350,979,601.51 267,264,411.30
1,929,999.77 27,094,861.24
24
2018
352,909,601.28 294,359,272.54
34,997,250.70 15,093,270.13
80,155,988.98 74,310,922.78
40,382,343.38 36,580,423.62
107,025,552.16 96,375,768.20
262,561,135.22 222,360,384.73
90,348,466.06 71,998,887.81
56,867,808.22 439,133,644.44
8,718.00 120,300.00
56,876,526.22 439,253,944.44
88,779,602.88 70,623,522.32
57,156,368.00 161,073,160.00
145,935,970.88 231,696,682.32
-89,059,444.66 207,557,262.12
50,000,000.00
50,000,000.00
100,000,000.00
25
2018
3,758,361.12
94,680,000.00 38,210,000.00
98,438,361.12 38,210,000.00
1,561,638.88 -38,210,000.00
-7.60 -1.18
2,850,652.68 241,346,148.75
154,033,483.24 135,110,121.16
156,884,135.92 376,456,269.91
26
贝达药业股份有限公司董事、高级管理人员
关于《2018 年第一季度报告》的书面确认意见
根据《证券法》第六十八条的规定，以及《创业板信息披露业务备忘录第 10
号：定期报告披露相关事项（2018 年 2 月修订）》等法律法规和交易所规则的相关
要求，作为贝达药业股份有限公司的董事、高级管理人员，我们在全面审核公司
《2018 年第一季度报告》后认为：
公司严格按照公司财务制度规范运作，公司《2018 年第一季度报告》包含的
信息公允、全面、真实地反映了公司本报告期的财务状况和经营成果等事项。
我们保证公司《2018 年第一季度报告》所披露的信息真实、准确、完整，承
诺本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容
的真实性、准确性和完整性承担个别及连带责任。
（以下无正文）